Carregant...

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease

An efficient method to identify whether mild cognitive impairment (MCI) has progressed to Alzheimer’s disease (AD) will be beneficial to patient care. Previous studies have shown that magnetic resonance imaging (MRI) has enabled the assessment of AD progression based on imaging findings. The present...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Neurosci
Autors principals: Kung, Te-Han, Chao, Tzu-Cheng, Xie, Yi-Ru, Pai, Ming-Chyi, Kuo, Yu-Min, Lee, Gwo Giun Chris
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7968420/
https://ncbi.nlm.nih.gov/pubmed/33746695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2021.584641
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!